A contemporary molecular view of diffuse gliomas with implications for diagnosis

by Jiabo Li, Xuya Wang, Luqing Tong, Xuejun Yang, Daniel J Brat
Published 2020-01-01

Immunological and clinicopathological characteristics of C1RL in 2120 glioma patients

by Junyou Wang, Luqing Tong, Gaojun Lin, Hui Wang, Liang Zhang, Xuejun Yang
Published 2020-09-01

IKBKE, a prognostic factor preferentially expressed in mesenchymal glioblastoma, modulates tumoral immunosuppression through the STAT3/PD‐L1 pathway

by Li Yi, Gaochao Guo, Jiabo Li, Xiaoguang Fan, Tao Li, Luqing Tong, Peidong Liu, Xuya Wang, Feng Yuan, Shengping Yu, Qiang Huang, Xuejun Yang
Published 2020-07-01

Notch1 signaling pathway promotes invasion, self-renewal and growth of glioma initiating cells via modulating chemokine system CXCL12/CXCR4

by Li Yi, Xingchen Zhou, Tao Li, Peidong Liu, Long Hai, Luqing Tong, Haiwen Ma, Zhennan Tao, Yang Xie, Chen Zhang, Shengping Yu, Xuejun Yang
Published 2019-08-01

Sustained localized delivery of immunotherapy to lymph nodes reverses immunosuppression and increases long-term survival in murine glioblastoma

by John Choi, Ayush Pant, Ravi Medikonda, Young-Hoon Kim, Denis Routkevitch, Laura Saleh, Luqing Tong, Hok Yee Chan, Jessie Nedrow, Christopher Jackson, Christina Jackson, Michael Lim
Published 2021-01-01

Identification of Key Pathways and Genes in the Orai2 Mediated Classical and Mesenchymal Subtype of Glioblastoma by Bioinformatic Analyses

by Feng Yuan, Li Yi, Long Hai, Yingshuai Wang, Yihan Yang, Tao Li, Luqing Tong, Haiwen Ma, Peidong Liu, Haolang Ming, Bingcheng Ren, Shengping Yu, Yu Lin, Xuejun Yang
Published 2019-01-01

Combination checkpoint therapy with anti-PD-1 and anti-BTLA results in a synergistic therapeutic effect against murine glioblastoma

by John Choi, Ravi Medikonda, Laura Saleh, Timothy Kim, Ayush Pant, Siddhartha Srivastava, Young-Hoon Kim, Christina Jackson, Luqing Tong, Denis Routkevitch, Christopher Jackson, Dimitrios Mathios, Tianna Zhao, Hyerim Cho, Henry Brem, Michael Lim
Published 2021-01-01

Jagged1 is Clinically Prognostic and Promotes Invasion of Glioma-Initiating Cells by Activating NF-κB(p65) Signaling

by Long Hai, Peidong Liu, Shengping Yu, Li Yi, Zhennan Tao, Chen Zhang, Iruni Roshanie Abeysekera, Tao Li, Luqing Tong, Haiwen Ma, Bo Liu, Yang Xie, Xingchen Zhou, Yu Lin, Meng Zhu, Kai Zhang, Bingcheng Ren, Haolang Ming, Yubao Huang, Xuejun  Yang
Published 2018-12-01